BiotechTube
Home/Cabaletta Bio/Samik Basu, M.D.
SB

Samik Basu, M.D.

Chief Scientific Officer

Cabaletta Bio

Therapeutic Areas

Autoimmune DiseasesRheumatologyDermatologyNeurology

Cabaletta Bio Pipeline

DrugIndicationPhase
rese-cel (resecabtagene autoleucel)Systemic Lupus Erythematosus (SLE)Phase 1/2

Leadership Team at Cabaletta Bio

SN
Steven Nichtberger, M.D.
President, Chief Executive Officer, and Co-Founder
GB
Gwendolyn Binder, Ph.D.
President, Science & Technology
CB
Catherine Bollard, M.D.
Independent Director
View full Cabaletta Bio profile